| BLUJEPA Glaxo Group Limited
98126258 10 Aug 2023 | on 22 Oct 2024
| Vaccines; Anti-infectives; Pharmaceutical preparations and substances ... Class 005 Class 005 Pharmaceutical Products The mark consists of the word "BLUJEPA" to the left of a stylized bow and arrow. | | | Logo Mark Glaxo Group Limited
98126260 10 Aug 2023 | on 22 Oct 2024
| Vaccines; Anti-infectives; Pharmaceutical preparations and substances ... Class 005 Class 005 Pharmaceutical Products The mark consists of a stylized bow and arrow. | | | KEPZAVYQ Glaxo Group Limited
97541157 09 Aug 2022 | on 15 Oct 2024
| Vaccines; Pharmaceutical preparations and substances for the treatment... Class 005 Class 005 Pharmaceutical Products Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | NUCALA Glaxo Group Limited
85371627 14 Jul 2011 | on 27 Aug 2024
| [ Pharmaceutical preparations and substances for the treatment of dama... Class 005 Class 005 Pharmaceutical Products [ Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; ] Pharmaceutical preparations and substances for the treatment of [ viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, ] respiratory, [ neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related ] diseases and disorders [ ; Vaccines ] | | | BLENREP Glaxo Group Limited
98155191 29 Aug 2023 | on 20 Aug 2024
| Pharmaceutical preparations and substances for treatment of oncologica... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for treatment of oncological diseases and disorders | | | Logo Mark Glaxo Group Limited
86149847 20 Dec 2013 | on 19 Aug 2024
| Inhalers filled with pharmaceutical preparations for the treatment and... Class 005 Class 005 Pharmaceutical Products The mark consists of a configuration of a medical device, namely, an inhaler with an overall rounded shape, and a movable closure with an overall triangular shape and three curved lines at the top of the device. The mark includes six curved lines on the side of the device and a counter box in the center and towards the bottom of the device. The counter box is not claimed as a feature of the mark. | | | ANORO ELLIPTA Glaxo Group Limited
85831335 24 Jan 2013 | on 19 Aug 2024
| Inhalers filled with pharmaceutical preparations for the treatment and... Class 005 Class 005 Pharmaceutical Products Inhalers filled with pharmaceutical preparations for the treatment and alleviation of respiratory ailments | | | Logo Mark Glaxo Group Limited
86149861 20 Dec 2013 | on 19 Aug 2024
| Inhalers filled with pharmaceutical preparations for the treatment and... Class 005 Class 005 Pharmaceutical Products The mark consists of a configuration of a medical device, namely, an inhaler with an overall rounded shape, and a movable closure with an overall triangular shape and three curved lines at the top of the device. The mark includes six curved lines on the side of the device and a counter box in the center and towards the bottom of the device. The counter box is not claimed as a feature of the mark. | | | Logo Mark Glaxo Group Limited
86149834 20 Dec 2013 | on 18 Aug 2024
| Inhalers filled with pharmaceutical preparations for the treatment and... Class 005 Class 005 Pharmaceutical Products The mark consists of a configuration of a medical device, namely, an inhaler with an overall rounded shape featuring an indented mouthpiece on the top side with an overall semi-circular shape. The inhaler also features an exterior movable closure with an overall triangular shape and three curved lines, which rests towards the bottom and side of the inhaler when the inhaler is opened. The device features six curved lines and a rectangular opening on the front of the device below the mouthpiece. The mark includes six curved lines on the side of the device and a counter box in the center and towards the bottom of the device. The indented mouthpiece, rectangular opening below the mouthpiece, and counter box are not claimed as features of the mark. | | | ZABTESI Glaxo Group Limited
98095382 21 Jul 2023 | on 30 Jul 2024
| Vaccines; Anti-infectives; Pharmaceutical preparations and substances ... Class 005 Class 005 Pharmaceutical Products Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | |